203 related articles for article (PubMed ID: 35956932)
1. MD Simulation Studies for Selective Phytochemicals as Potential Inhibitors against Major Biological Targets of Diabetic Nephropathy.
Kausar MA; Anwar S; Eltayb WA; Kuddus M; Khatoon F; El-Arabey AA; Khalifa AM; Rizvi MR; Najm MZ; Thakur L; Kar S; Abdalla M
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956932
[TBL] [Abstract][Full Text] [Related]
2. Metabolic memory and diabetic nephropathy: Beneficial effects of natural epigenetic modifiers.
Kushwaha K; Sharma S; Gupta J
Biochimie; 2020 Mar; 170():140-151. PubMed ID: 31954720
[TBL] [Abstract][Full Text] [Related]
3. In silico identification of potential drug compound against Peroxisome proliferator-activated receptor-gamma by virtual screening and toxicity studies for the treatment of Diabetic Nephropathy.
Singh S; Mohanty A
J Biomol Struct Dyn; 2018 May; 36(7):1776-1787. PubMed ID: 28539091
[TBL] [Abstract][Full Text] [Related]
4. Nephroprotective effect of Combretum micranthum G. Don in nicotinamide-streptozotocin induced diabetic nephropathy in rats: In-vivo and in-silico experiments.
Kpemissi M; Potârniche AV; Lawson-Evi P; Metowogo K; Melila M; Dramane P; Taulescu M; Chandramohan V; Suhas DS; Puneeth TA; S VK; Vlase L; Andrei S; Eklu-Gadegbeku K; Sevastre B; Veerapur VP
J Ethnopharmacol; 2020 Oct; 261():113133. PubMed ID: 32673708
[TBL] [Abstract][Full Text] [Related]
5. Diabetic nephropathy: new approaches for improving glycemic control and reducing risk.
Schernthaner G; Schernthaner GH
J Nephrol; 2013; 26(6):975-85. PubMed ID: 23807645
[TBL] [Abstract][Full Text] [Related]
6. In Silico Screening and Identification of Antidiabetic Inhibitors Sourced from Phytochemicals of Philippine Plants against Four Protein Targets of Diabetes (PTP1B, DPP-4, SGLT-2, and FBPase).
Macalalad MAB; Gonzales AA
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513175
[TBL] [Abstract][Full Text] [Related]
7.
Oyeyemi IT; Adewole KE; Gyebi GA
J Biomol Struct Dyn; 2023; 41(21):12225-12241. PubMed ID: 36645154
[No Abstract] [Full Text] [Related]
8. Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats.
Peng CH; Lin HC; Lin CL; Wang CJ; Huang CN
J Food Drug Anal; 2019 Jan; 27(1):135-144. PubMed ID: 30648566
[TBL] [Abstract][Full Text] [Related]
9. Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy.
Ma W; Wang KJ; Cheng CS; Yan GQ; Lu WL; Ge JF; Cheng YX; Li N
J Ethnopharmacol; 2014 May; 153(3):840-5. PubMed ID: 24694395
[TBL] [Abstract][Full Text] [Related]
10. Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach.
Nazir N; Zahoor M; Nisar M; Khan I; Karim N; Abdel-Halim H; Ali A
BMC Complement Altern Med; 2018 Dec; 18(1):332. PubMed ID: 30545352
[TBL] [Abstract][Full Text] [Related]
11. Bioactive phytochemicals that regulate the cellular processes involved in diabetic nephropathy.
Parveen A; Jin M; Kim SY
Phytomedicine; 2018 Jan; 39():146-159. PubMed ID: 29433676
[TBL] [Abstract][Full Text] [Related]
12. Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response.
Khanra R; Dewanjee S; K Dua T; Sahu R; Gangopadhyay M; De Feo V; Zia-Ul-Haq M
J Transl Med; 2015 Jan; 13():6. PubMed ID: 25591455
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
Dong Y; Zhao Q; Wang Y
Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
[TBL] [Abstract][Full Text] [Related]
14. Anti-fibrosis therapy and diabetic nephropathy.
Karihaloo A
Curr Diab Rep; 2012 Aug; 12(4):414-22. PubMed ID: 22644874
[TBL] [Abstract][Full Text] [Related]
15. In Silico Computations of Selective Phytochemicals as Potential Inhibitors Against Major Biological Targets of Diabetes Mellitus.
Akhtar A; Amir A; Hussain W; Ghaffar A; Rasool N
Curr Comput Aided Drug Des; 2019; 15(5):401-408. PubMed ID: 30706825
[TBL] [Abstract][Full Text] [Related]
16. Finding needles in a haystack: application of network analysis and target enrichment studies for the identification of potential anti-diabetic phytochemicals.
Fayaz SM; Suvanish Kumar VS; Rajanikant KG
PLoS One; 2014; 9(11):e112911. PubMed ID: 25396726
[TBL] [Abstract][Full Text] [Related]
17. In silico screening of potential antidiabetic phytochemicals from Phyllanthus emblica against therapeutic targets of type 2 diabetes.
Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
J Ethnopharmacol; 2020 Feb; 248():112268. PubMed ID: 31593813
[TBL] [Abstract][Full Text] [Related]
18. An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy.
Li KX; Ji MJ; Sun HJ
Gene; 2021 May; 780():145532. PubMed ID: 33631244
[TBL] [Abstract][Full Text] [Related]
19. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
Ruilope LM; Segura J
Clin Ther; 2003 Dec; 25(12):3044-64. PubMed ID: 14749145
[TBL] [Abstract][Full Text] [Related]
20. Current update in the management of diabetic nephropathy.
Van Buren PN; Toto R
Curr Diabetes Rev; 2013 Jan; 9(1):62-77. PubMed ID: 23167665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
